HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Investment analysts at Northland Securities lowered their FY2026 earnings estimates for HIVE Blockchain Technologies in a research note issued on Tuesday, February 17th. Northland Securities analyst M. Grondahl now anticipates that the company will post earnings per share of ($0.76) for the year, down from their prior estimate of ($0.42). Northland Securities also issued estimates for HIVE Blockchain Technologies’ Q4 2026 earnings at ($0.30) EPS, Q1 2027 earnings at ($0.30) EPS, Q2 2027 earnings at ($0.29) EPS, Q3 2027 earnings at ($0.27) EPS, Q4 2027 earnings at ($0.20) EPS and FY2027 earnings at ($1.05) EPS.
Several other research firms have also issued reports on HIV. Keefe, Bruyette & Woods lowered HIVE Blockchain Technologies from a “moderate buy” rating to a “hold” rating in a report on Tuesday, January 27th. B. Riley Financial raised HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Friday, November 21st. Two research analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy”.
HIVE Blockchain Technologies Price Performance
HIVE Blockchain Technologies Ltd. is a business services company in the Business Services industry.
Featured Stories
- Five stocks we like better than HIVE Blockchain Technologies
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
